Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|6|788-795

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.6, 2015-05, pp. : 788-795

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coffee consumption and risk of levodopa‐induced dyskinesia in Parkinson's disease: The FRAGAMP study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 13, 2015-11 ,pp. : 1854-1856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct Effect of Subthalamic Nucleus Stimulation on Levodopa-Induced Peak-Dose Dyskinesia in Patients with Parkinson’s Disease

By  

Stereotactic and Functional Neurosurgery, Vol. 84, Iss. 4, 2006-09 ,pp. : 176-179

Karger

Access to resources Recommend Favorite

Serotonergic markers in Parkinson's disease and levodopa‐induced dyskinesias

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 6, 2015-05 ,pp. : 796-804

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nicotine reduces established levodopa‐induced dyskinesias in a monkey model of Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 28, Iss. 10, 2013-09 ,pp. : 1398-1406

John Wiley & Sons Inc

Access to resources Recommend Favorite

The motor inhibition system in Parkinson's disease with levodopa‐induced dyskinesias

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 14, 2015-12 ,pp. : 1912-1920

John Wiley & Sons Inc

Access to resources Recommend Favorite